MTOR and urinary bladder carcinoma: Downregulation of PKM2 reduces FASN expression and inhibits bladder cancer cell growth by significantly reducing the phosphorylation of both AKT and mTOR and inactivating the AKT/mTOR/SREBP1c signaling pathway (Tao et al., 2019).